Sort
17,288 grants matching “multiple sclerosis”
LEUKOCYTE RECRUITMENT AND ACTIVATION DURING INFLAMMATION
$5,641Kamala D Patel · Marine Biological Laboratory · P41 · FY2008 · RR
RECEPTORS INVOLVED IN MULTIPLE SCLEROSIS
$5,526University Of Chicago · P41 · FY2004 · RR
Neurodegeneration in multiple sclerosis: Effects of mitochondrial dysfunction and
$5,508Kimmy Ger-Wen Su · Oregon Health & Science University · F30 · FY2013 · NS
A 6BETA 1 INTEGRIN-MEDIATED SURVIVAL OF OLIGODENDROCYTES
$5,500University Of Cambridge · F32 · FY2002 · NS
THE CLINICO-PATHOLOGICAL CORRELATES OF THE MULTIPLE SCLEROSIS LESION
$5,450Mayo Clinic · M01 · FY2005 · RR
STRUCTURAL CHANGES IN HUMAN SOD1 BY POST-TRANLATIONAL MODIFICATION
$5,442Osman Bilsel · Illinois Institute Of Technology · P41 · FY2010 · RR
HOME-BASED AEROBIC EXERCISE FOR PERSONS WITH MULTIPLE SCLEROSIS
$5,380Virgil Mathiowetz · University Of Minnesota · M01 · FY2006 · RR
Quantitative MR Imaging and Proton Spectroscopy in Multiple Sclerosis
$5,335New York University School Of Medicine · M01 · FY2004 · RR
PROTEOMIC ANALYSIS OF PEDIATRIC MULTIPLE SCLEROSIS (MS), A PILOT STUDY
$5,224Lauren B Krupp · State University New York Stony Brook · M01 · FY2008 · RR
The Effects of Avonex on Fatigue Components in MS
$5,221University Of Rochester · M01 · FY2004 · RR
A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE
$5,153Rhonda R Voskuhl · University Of California Los Angeles · P41 · FY2008 · RR
HIPPOCAMPAL VOLUME LOSS IN MULTIPLE SCLEROSIS: CLINICAL CONSEQUENCES
$5,153Nancy L Sicotte · University Of California Los Angeles · P41 · FY2008 · RR
Establishing the Causal Role of Low Vitamin D in Multiple Sclerosis
$5,071Brooke Rhead · University Of California Berkeley · F31 · FY2019 · NS
COMPLEX OF TCR/HLA-DR2/MBP-PEPTIDE
$5,059Kai W Wucherpfennig · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2007 · RR
FASEB Summer Conference on 'Autoimmunity'
$5,001Matthias G. Von Herrath · Federation Of Amer Soc For Exper Biology · R13 · FY2008 · AI
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE
$5,001Medical University Of South Carolina · R01 · FY2002 · NS
CSHL 2016 Blood Brain Barrier Conference
$5,000David J. Stewart · Cold Spring Harbor Laboratory · R13 · FY2016 · NS
MECHANISMS OF IMMUNOLOGIC TOLERANCE AND ITS BREAKDOWN
$5,000Keystone Symposia · R13 · FY2000 · AI
The Annual Blood-Brain Barrier Consortium Meeting
$5,000Edward A Neuwelt · Oregon Health & Science University · R13 · FY2010 · CA
A 6BETA 1 INTEGRIN-MEDIATED SURVIVAL OF OLIGODENDROCYTES
$5,000University Of Cambridge · F32 · FY2001 · NS
Neuroinflammation in Diseases of the Central Nervous System
$5,000David L Woodland · Keystone Symposia · R13 · FY2014 · NS
EVALUATION OF NOVEL SPIO CONTRAST AGENTS IN A MODEL OF MULTIPLE SCLEROSIS
$4,985Dan M Meyer · Duke University · P41 · FY2007 · RR
Assessing Antibiotic therapy for C.pneumoniae in the CNS of MS patients
$4,952Vanderbilt University · M01 · FY2004 · RR
PHOTOBIOLOGY OF VITAMIN D
$4,940Boston University Medical Campus · P41 · FY2000 · RR
CYCLOPHOSPHAMIDE IN THE TREATMENT OF MULTIPLE SCLEROSIS
$4,932Douglas S Kerr · Johns Hopkins University · M01 · FY2006 · RR